Summary

The global Anti-CD4 Antibody market size was US$ million in 2025 and is forecast to reach a readjusted size of US$ million by 2032 with a CAGR of %during the forecast period 2026-2032.
An Anti-CD4 Antibody is a biological molecule, specifically a type of immunoglobulin (IgG), that recognizes and binds to the CD4 protein found on the surface of certain immune cells, such as T-cells. This antibody plays a crucial role in the immune response, as it helps to regulate and modulate immune cell activity. In medical contexts, Anti-CD4 Antibodies are used as therapeutic agents to treat various immune-mediated disorders, including autoimmune diseases and HIV infection. These antibodies are often prescribed in combination with other medications to suppress the immune system and prevent organ transplant rejection or graft-versus-host disease after a stem cell transplant.
The industry trend for Anti-CD4 Antibodies has been growing in recent years due to an increasing demand for novel therapeutics and the ongoing research in the field of immunology and autoimmune disease treatment. The development of biosimilar versions of existing Anti-CD4 Antibodies has also contributed to the trend. Some factors driving this growth include advancements in biotechnology and pharmaceutical research, as well as a greater understanding of the immune system"s role in various diseases. Additionally, as the global population ages, the demand for immunomodulatory therapies is expected to rise, further driving the industry forward. However, the market is competitive, and companies must invest in research and development to ensure their products stand out in a crowded landscape. Furthermore, stringent regulatory requirements and the potential for immunological side effects associated with Anti-CD4 Antibodies continue to challenge the industry. Nonetheless, the overall trend indicates a promising future for Anti-CD4 Antibody research and application in therapeutics.
The global Anti-CD4 Antibody market is strategically segmented by company, region (country), by Type, and by Application. This report empowers stakeholders to capitalize on emerging opportunities, optimize product strategies, and outperform competitors through data-driven insights on revenue and forecasts across regions, by Type, and by Application for 2021-2032.
Market Segmentation
By Company:
BosterBio
ProSci
Bio-Rad
Bioss
Thermo Fisher Scientific
Biorbyt
Abbexa
Mabtech
Bio X Cell
R&D Systems
MyBioSource
GeneTex
OriGene Technologies
Novus Biologicals
LSBio
NSJ Bioreagents
Abnova Corporation
G Biosciences
EpiGentek
Elabscience Bionovation
Santa Cruz Biotechnology
RayBiotech
HUABIO
Cell Signaling Technology
Miltenyi Biotec
Kerafast
SouthernBiotech
Absolute Antibody
St John's Laboratory
Leading Biology
Segment by Type
Monoclonal Antibody
Polyclonal Antibody
Segment by Application
Biotechnology
Medical
University
Others
By Region
Macro-Region
- North America
- Europe
- Asia-Pacific
- South America
- Middle East & Africa
Micro-Local Markets
North America
Europe
Asia-Pacific
Latin America
Middle East & Africa
(Additional regions can be customized based on client needs.)
Chapter 1: Report scope, executive summary, and market evolution scenarios (short/mid/long term)
Chapter 2: Quantitative analysis of Anti-CD4 Antibody market size and growth potential at global, regional, and country levels
Chapter 3: Competitive benchmarking of manufacturers (revenue, market share, M&A, R&D focus)
Chapter 4: Type-based segmentation analysis – Uncovering blue ocean markets
Chapter 5: Application-based segmentation analysis – High-growth downstream opportunities
Chapter 6: Regional revenue breakdown by company, type, application and customer
Chapter 7: Key manufacturer profiles – Financials, product portfolios, and strategic developments
Chapter 8: Market dynamics – Drivers, restraints, regulatory impacts, and risk mitigation strategies
Chapter 9: Actionable conclusions and strategic recommendations.
Why This Report?
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Anti-CD4 Antibody value chain, addressing:
- Market entry risks/opportunities by region
- Product mix optimization based on local practices
- Competitor tactics in fragmented vs. consolidated markets

ページTOPに戻る

Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Market by Type
1.2.1 Global Market Size and Growth by Type: 2021 vs 2025 vs 2032
1.2.2 Monoclonal Antibody
1.2.3 Polyclonal Antibody
1.3 Market by Application
1.3.1 Global Market Share by Application: 2021 vs 2025 vs 2032
1.3.2 Biotechnology
1.3.3 Medical
1.3.4 University
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Anti-CD4 Antibody Market Perspective (2021-2032)
2.2 Global Market Size by Region: 2021 vs 2025 vs 2032
2.3 Global Anti-CD4 Antibody Market Share by Revenue, by Region (2021-2026)
2.4 Global Anti-CD4 Antibody Revenue Forecast by Region (2027-2032)
2.5 Major Regions and Emerging Markets Analysis
2.5.1 North America Anti-CD4 Antibody Market Size and Prospective (2021-2032)
2.5.2 Europe Anti-CD4 Antibody Market Size and Prospective (2021-2032)
2.5.3 Asia-Pacific Anti-CD4 Antibody Market Size and Prospective (2021-2032)
2.5.4 Latin America Anti-CD4 Antibody Market Size and Prospective (2021-2032)
2.5.5 Middle East & Africa Anti-CD4 Antibody Market Size and Prospective (2021-2032)
3 Breakdown Data by Type
3.1 Global Anti-CD4 Antibody Historical Market Size by Type (2021-2026)
3.2 Global Anti-CD4 Antibody Forecasted Market Size by Type (2027-2032)
3.3 Representative Players for Different Types of Anti-CD4 Antibody
4 Breakdown Data by Application
4.1 Global Anti-CD4 Antibody Historical Market Size by Application (2021-2026)
4.2 Global Anti-CD4 Antibody Forecasted Market Size by Application (2027-2032)
4.3 New Sources of Growth in Anti-CD4 Antibody Applications
5 Competitive Landscape by Players
5.1 Global Top Players by Revenue
5.1.1 Global Top Anti-CD4 Antibody Players by Revenue (2021-2026)
5.1.2 Global Anti-CD4 Antibody Market Share by Revenue, by Players (2021-2026)
5.2 Global Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
5.3 Players Covered: Ranking by Anti-CD4 Antibody Revenue
5.4 Global Anti-CD4 Antibody Market Concentration Analysis
5.4.1 Global Anti-CD4 Antibody Market Concentration Ratio (CR5 and HHI)
5.4.2 Global Top 10 and Top 5 Companies by Anti-CD4 Antibody Revenue in 2025
5.5 Global Key Players of Anti-CD4 Antibody Head Offices and Areas Served
5.6 Global Key Players of Anti-CD4 Antibody, Product and Application
5.7 Global Key Players of Anti-CD4 Antibody, Date of Entry into This Industry
5.8 Mergers & Acquisitions, Expansion Plans
6 Region Analysis
6.1 North America Market: Players, Segments, Downstream and Major Customers
6.1.1 North America Anti-CD4 Antibody Revenue by Company (2021-2026)
6.1.2 North America Market Size by Type
6.1.2.1 North America Anti-CD4 Antibody Market Size by Type (2021-2026)
6.1.2.2 North America Anti-CD4 Antibody Market Share by Type (2021-2026)
6.1.3 North America Market Size by Application
6.1.3.1 North America Anti-CD4 Antibody Market Size by Application (2021-2026)
6.1.3.2 North America Anti-CD4 Antibody Market Share by Application (2021-2026)
6.1.4 North America Anti-CD4 Antibody Major Customers
6.1.5 North America Market Trends and Opportunities
6.2 Europe Market: Players, Segments, Downstream and Major Customers
6.2.1 Europe Anti-CD4 Antibody Revenue by Company (2021-2026)
6.2.2 Europe Market Size by Type
6.2.2.1 Europe Anti-CD4 Antibody Market Size by Type (2021-2026)
6.2.2.2 Europe Anti-CD4 Antibody Market Share by Type (2021-2026)
6.2.3 Europe Market Size by Application
6.2.3.1 Europe Anti-CD4 Antibody Market Size by Application (2021-2026)
6.2.3.2 Europe Anti-CD4 Antibody Market Share by Application (2021-2026)
6.2.4 Europe Anti-CD4 Antibody Major Customers
6.2.5 Europe Market Trends and Opportunities
6.3 Asia-Pacific Market: Players, Segments, Downstream and Major Customers
6.3.1 Asia-Pacific Anti-CD4 Antibody Revenue by Company (2021-2026)
6.3.2 Asia-Pacific Market Size by Type
6.3.2.1 Asia-Pacific Anti-CD4 Antibody Market Size by Type (2021-2026)
6.3.2.2 Asia-Pacific Anti-CD4 Antibody Market Share by Type (2021-2026)
6.3.3 Asia-Pacific Market Size by Application
6.3.3.1 Asia-Pacific Anti-CD4 Antibody Market Size by Application (2021-2026)
6.3.3.2 Asia-Pacific Anti-CD4 Antibody Market Share by Application (2021-2026)
6.3.4 Asia-Pacific Anti-CD4 Antibody Major Customers
6.3.5 Asia-Pacific Market Trends and Opportunities
6.4 Latin America Market: Players, Segments, Downstream and Major Customers
6.4.1 Latin America Anti-CD4 Antibody Revenue by Company (2021-2026)
6.4.2 Latin America Market Size by Type
6.4.2.1 Latin America Anti-CD4 Antibody Market Size by Type (2021-2026)
6.4.2.2 Latin America Anti-CD4 Antibody Market Share by Type (2021-2026)
6.4.3 Latin America Market Size by Application
6.4.3.1 Latin America Anti-CD4 Antibody Market Size by Application (2021-2026)
6.4.3.2 Latin America Anti-CD4 Antibody Market Share by Application (2021-2026)
6.4.4 Latin America Anti-CD4 Antibody Major Customers
6.4.5 Latin America Market Trends and Opportunities
6.5 Middle East & Africa Market: Players, Segments, Downstream and Major Customers
6.5.1 Middle East & Africa Anti-CD4 Antibody Revenue by Company (2021-2026)
6.5.2 Middle East & Africa Market Size by Type
6.5.2.1 Middle East & Africa Anti-CD4 Antibody Market Size by Type (2021-2026)
6.5.2.2 Middle East & Africa Anti-CD4 Antibody Market Share by Type (2021-2026)
6.5.3 Middle East & Africa Market Size by Application
6.5.3.1 Middle East & Africa Anti-CD4 Antibody Market Size by Application (2021-2026)
6.5.3.2 Middle East & Africa Anti-CD4 Antibody Market Share by Application (2021-2026)
6.5.4 Middle East & Africa Anti-CD4 Antibody Major Customers
6.5.5 Middle East & Africa Market Trends and Opportunities
7 Key Player Profiles
7.1 BosterBio
7.1.1 BosterBio Company Details
7.1.2 BosterBio Business Overview
7.1.3 BosterBio Anti-CD4 Antibody Introduction
7.1.4 BosterBio Revenue in Anti-CD4 Antibody Business (2021-2026)
7.1.5 BosterBio Recent Development
7.2 ProSci
7.2.1 ProSci Company Details
7.2.2 ProSci Business Overview
7.2.3 ProSci Anti-CD4 Antibody Introduction
7.2.4 ProSci Revenue in Anti-CD4 Antibody Business (2021-2026)
7.2.5 ProSci Recent Development
7.3 Bio-Rad
7.3.1 Bio-Rad Company Details
7.3.2 Bio-Rad Business Overview
7.3.3 Bio-Rad Anti-CD4 Antibody Introduction
7.3.4 Bio-Rad Revenue in Anti-CD4 Antibody Business (2021-2026)
7.3.5 Bio-Rad Recent Development
7.4 Bioss
7.4.1 Bioss Company Details
7.4.2 Bioss Business Overview
7.4.3 Bioss Anti-CD4 Antibody Introduction
7.4.4 Bioss Revenue in Anti-CD4 Antibody Business (2021-2026)
7.4.5 Bioss Recent Development
7.5 Thermo Fisher Scientific
7.5.1 Thermo Fisher Scientific Company Details
7.5.2 Thermo Fisher Scientific Business Overview
7.5.3 Thermo Fisher Scientific Anti-CD4 Antibody Introduction
7.5.4 Thermo Fisher Scientific Revenue in Anti-CD4 Antibody Business (2021-2026)
7.5.5 Thermo Fisher Scientific Recent Development
7.6 Biorbyt
7.6.1 Biorbyt Company Details
7.6.2 Biorbyt Business Overview
7.6.3 Biorbyt Anti-CD4 Antibody Introduction
7.6.4 Biorbyt Revenue in Anti-CD4 Antibody Business (2021-2026)
7.6.5 Biorbyt Recent Development
7.7 Abbexa
7.7.1 Abbexa Company Details
7.7.2 Abbexa Business Overview
7.7.3 Abbexa Anti-CD4 Antibody Introduction
7.7.4 Abbexa Revenue in Anti-CD4 Antibody Business (2021-2026)
7.7.5 Abbexa Recent Development
7.8 Mabtech
7.8.1 Mabtech Company Details
7.8.2 Mabtech Business Overview
7.8.3 Mabtech Anti-CD4 Antibody Introduction
7.8.4 Mabtech Revenue in Anti-CD4 Antibody Business (2021-2026)
7.8.5 Mabtech Recent Development
7.9 Bio X Cell
7.9.1 Bio X Cell Company Details
7.9.2 Bio X Cell Business Overview
7.9.3 Bio X Cell Anti-CD4 Antibody Introduction
7.9.4 Bio X Cell Revenue in Anti-CD4 Antibody Business (2021-2026)
7.9.5 Bio X Cell Recent Development
7.10 R&D Systems
7.10.1 R&D Systems Company Details
7.10.2 R&D Systems Business Overview
7.10.3 R&D Systems Anti-CD4 Antibody Introduction
7.10.4 R&D Systems Revenue in Anti-CD4 Antibody Business (2021-2026)
7.10.5 R&D Systems Recent Development
7.11 MyBioSource
7.11.1 MyBioSource Company Details
7.11.2 MyBioSource Business Overview
7.11.3 MyBioSource Anti-CD4 Antibody Introduction
7.11.4 MyBioSource Revenue in Anti-CD4 Antibody Business (2021-2026)
7.11.5 MyBioSource Recent Development
7.12 GeneTex
7.12.1 GeneTex Company Details
7.12.2 GeneTex Business Overview
7.12.3 GeneTex Anti-CD4 Antibody Introduction
7.12.4 GeneTex Revenue in Anti-CD4 Antibody Business (2021-2026)
7.12.5 GeneTex Recent Development
7.13 OriGene Technologies
7.13.1 OriGene Technologies Company Details
7.13.2 OriGene Technologies Business Overview
7.13.3 OriGene Technologies Anti-CD4 Antibody Introduction
7.13.4 OriGene Technologies Revenue in Anti-CD4 Antibody Business (2021-2026)
7.13.5 OriGene Technologies Recent Development
7.14 Novus Biologicals
7.14.1 Novus Biologicals Company Details
7.14.2 Novus Biologicals Business Overview
7.14.3 Novus Biologicals Anti-CD4 Antibody Introduction
7.14.4 Novus Biologicals Revenue in Anti-CD4 Antibody Business (2021-2026)
7.14.5 Novus Biologicals Recent Development
7.15 LSBio
7.15.1 LSBio Company Details
7.15.2 LSBio Business Overview
7.15.3 LSBio Anti-CD4 Antibody Introduction
7.15.4 LSBio Revenue in Anti-CD4 Antibody Business (2021-2026)
7.15.5 LSBio Recent Development
7.16 NSJ Bioreagents
7.16.1 NSJ Bioreagents Company Details
7.16.2 NSJ Bioreagents Business Overview
7.16.3 NSJ Bioreagents Anti-CD4 Antibody Introduction
7.16.4 NSJ Bioreagents Revenue in Anti-CD4 Antibody Business (2021-2026)
7.16.5 NSJ Bioreagents Recent Development
7.17 Abnova Corporation
7.17.1 Abnova Corporation Company Details
7.17.2 Abnova Corporation Business Overview
7.17.3 Abnova Corporation Anti-CD4 Antibody Introduction
7.17.4 Abnova Corporation Revenue in Anti-CD4 Antibody Business (2021-2026)
7.17.5 Abnova Corporation Recent Development
7.18 G Biosciences
7.18.1 G Biosciences Company Details
7.18.2 G Biosciences Business Overview
7.18.3 G Biosciences Anti-CD4 Antibody Introduction
7.18.4 G Biosciences Revenue in Anti-CD4 Antibody Business (2021-2026)
7.18.5 G Biosciences Recent Development
7.19 EpiGentek
7.19.1 EpiGentek Company Details
7.19.2 EpiGentek Business Overview
7.19.3 EpiGentek Anti-CD4 Antibody Introduction
7.19.4 EpiGentek Revenue in Anti-CD4 Antibody Business (2021-2026)
7.19.5 EpiGentek Recent Development
7.20 Elabscience Bionovation
7.20.1 Elabscience Bionovation Company Details
7.20.2 Elabscience Bionovation Business Overview
7.20.3 Elabscience Bionovation Anti-CD4 Antibody Introduction
7.20.4 Elabscience Bionovation Revenue in Anti-CD4 Antibody Business (2021-2026)
7.20.5 Elabscience Bionovation Recent Development
7.21 Santa Cruz Biotechnology
7.21.1 Santa Cruz Biotechnology Company Details
7.21.2 Santa Cruz Biotechnology Business Overview
7.21.3 Santa Cruz Biotechnology Anti-CD4 Antibody Introduction
7.21.4 Santa Cruz Biotechnology Revenue in Anti-CD4 Antibody Business (2021-2026)
7.21.5 Santa Cruz Biotechnology Recent Development
7.22 RayBiotech
7.22.1 RayBiotech Company Details
7.22.2 RayBiotech Business Overview
7.22.3 RayBiotech Anti-CD4 Antibody Introduction
7.22.4 RayBiotech Revenue in Anti-CD4 Antibody Business (2021-2026)
7.22.5 RayBiotech Recent Development
7.23 HUABIO
7.23.1 HUABIO Company Details
7.23.2 HUABIO Business Overview
7.23.3 HUABIO Anti-CD4 Antibody Introduction
7.23.4 HUABIO Revenue in Anti-CD4 Antibody Business (2021-2026)
7.23.5 HUABIO Recent Development
7.24 Cell Signaling Technology
7.24.1 Cell Signaling Technology Company Details
7.24.2 Cell Signaling Technology Business Overview
7.24.3 Cell Signaling Technology Anti-CD4 Antibody Introduction
7.24.4 Cell Signaling Technology Revenue in Anti-CD4 Antibody Business (2021-2026)
7.24.5 Cell Signaling Technology Recent Development
7.25 Miltenyi Biotec
7.25.1 Miltenyi Biotec Company Details
7.25.2 Miltenyi Biotec Business Overview
7.25.3 Miltenyi Biotec Anti-CD4 Antibody Introduction
7.25.4 Miltenyi Biotec Revenue in Anti-CD4 Antibody Business (2021-2026)
7.25.5 Miltenyi Biotec Recent Development
7.26 Kerafast
7.26.1 Kerafast Company Details
7.26.2 Kerafast Business Overview
7.26.3 Kerafast Anti-CD4 Antibody Introduction
7.26.4 Kerafast Revenue in Anti-CD4 Antibody Business (2021-2026)
7.26.5 Kerafast Recent Development
7.27 SouthernBiotech
7.27.1 SouthernBiotech Company Details
7.27.2 SouthernBiotech Business Overview
7.27.3 SouthernBiotech Anti-CD4 Antibody Introduction
7.27.4 SouthernBiotech Revenue in Anti-CD4 Antibody Business (2021-2026)
7.27.5 SouthernBiotech Recent Development
7.28 Absolute Antibody
7.28.1 Absolute Antibody Company Details
7.28.2 Absolute Antibody Business Overview
7.28.3 Absolute Antibody Anti-CD4 Antibody Introduction
7.28.4 Absolute Antibody Revenue in Anti-CD4 Antibody Business (2021-2026)
7.28.5 Absolute Antibody Recent Development
7.29 St John's Laboratory
7.29.1 St John's Laboratory Company Details
7.29.2 St John's Laboratory Business Overview
7.29.3 St John's Laboratory Anti-CD4 Antibody Introduction
7.29.4 St John's Laboratory Revenue in Anti-CD4 Antibody Business (2021-2026)
7.29.5 St John's Laboratory Recent Development
7.30 Leading Biology
7.30.1 Leading Biology Company Details
7.30.2 Leading Biology Business Overview
7.30.3 Leading Biology Anti-CD4 Antibody Introduction
7.30.4 Leading Biology Revenue in Anti-CD4 Antibody Business (2021-2026)
7.30.5 Leading Biology Recent Development
8 Anti-CD4 Antibody Market Dynamics
8.1 Anti-CD4 Antibody Industry Trends
8.2 Anti-CD4 Antibody Market Drivers
8.3 Anti-CD4 Antibody Market Challenges
8.4 Anti-CD4 Antibody Market Restraints
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.1.1 Research Programs/Design
10.1.1.2 Market Size Estimation
10.1.1.3 Market Breakdown and Data Triangulation
10.1.2 Data Source
10.1.2.1 Secondary Sources
10.1.2.2 Primary Sources
10.2 Author Details
10.3 Disclaimer

ページTOPに戻る

List of Tables/Graphs

List of Tables
Table 1. Global Anti-CD4 Antibody Market Size Growth Rate by Type (US$ Million): 2021 vs 2025 vs 2032
Table 2. Global Anti-CD4 Antibody Market Size Growth by Application (US$ Million): 2021 vs 2025 vs 2032
Table 3. Global Market Anti-CD4 Antibody Market Size (US$ Million) by Region:2021 vs 2025 vs 2032
Table 4. Global Anti-CD4 Antibody Revenue (US$ Million) Market Share by Region (2021-2026)
Table 5. Global Anti-CD4 Antibody Revenue Share by Region (2021-2026)
Table 6. Global Anti-CD4 Antibody Revenue (US$ Million) Forecast by Region (2027-2032)
Table 7. Global Anti-CD4 Antibody Revenue Share Forecast by Region (2027-2032)
Table 8. Global Anti-CD4 Antibody Market Size by Type (2021-2026) & (US$ Million)
Table 9. Global Anti-CD4 Antibody Market Share by Revenue, by Type (2021-2026)
Table 10. Global Anti-CD4 Antibody Forecasted Market Size by Type (2027-2032) & (US$ Million)
Table 11. Global Anti-CD4 Antibody Market Share by Revenue, by Type (2027-2032)
Table 12. Representative Players of Each Type
Table 13. Global Anti-CD4 Antibody Market Size by Application (2021-2026) & (US$ Million)
Table 14. Global Anti-CD4 Antibody Market Share by Revenue, by Application (2021-2026)
Table 15. Global Anti-CD4 Antibody Forecasted Market Size by Application (2027-2032) & (US$ Million)
Table 16. Global Anti-CD4 Antibody Market Share by Revenue, by Application (2027-2032)
Table 17. New Sources of Growth in Anti-CD4 Antibody Applications
Table 18. Global Anti-CD4 Antibody Revenue by Players (2021-2026) & (US$ Million)
Table 19. Global Anti-CD4 Antibody Market Share by Players (2021-2026)
Table 20. Global Top Anti-CD4 Antibody Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Anti-CD4 Antibody as of 2025)
Table 21. Ranking of Global Top Anti-CD4 Antibody Companies by Revenue (US$ Million) in 2025
Table 22. Global 5 Largest Players Market Share by Anti-CD4 Antibody Revenue (CR5 and HHI) & (2021-2026)
Table 23. Global Key Players of Anti-CD4 Antibody, Headquarters and Area Served
Table 24. Global Key Players of Anti-CD4 Antibody, Product and Application
Table 25. Global Key Players of Anti-CD4 Antibody, Date of Entry into This Industry
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. North America Anti-CD4 Antibody Revenue by Company (2021-2026) & (US$ Million)
Table 28. North America Anti-CD4 Antibody Market Share by Revenue, by Company (2021-2026)
Table 29. North America Anti-CD4 Antibody Market Size by Type (2021-2026) & (US$ Million)
Table 30. North America Anti-CD4 Antibody Market Size by Application (2021-2026) & (US$ Million)
Table 31. Europe Anti-CD4 Antibody Revenue by Company (2021-2026) & (US$ Million)
Table 32. Europe Anti-CD4 Antibody Market Share by Revenue, by Company (2021-2026)
Table 33. Europe Anti-CD4 Antibody Market Size by Type (2021-2026) & (US$ Million)
Table 34. Europe Anti-CD4 Antibody Market Size by Application (2021-2026) & (US$ Million)
Table 35. Asia-Pacific Anti-CD4 Antibody Revenue by Company (2021-2026) & (US$ Million)
Table 36. Asia-Pacific Anti-CD4 Antibody Market Share by Revenue, by Company (2021-2026)
Table 37. Asia-Pacific Anti-CD4 Antibody Market Size by Type (2021-2026) & (US$ Million)
Table 38. Asia-Pacific Anti-CD4 Antibody Market Size by Application (2021-2026) & (US$ Million)
Table 39. Latin America Anti-CD4 Antibody Revenue by Company (2021-2026) & (US$ Million)
Table 40. Latin America Anti-CD4 Antibody Market Share by Revenue, by Company (2021-2026)
Table 41. Latin America Anti-CD4 Antibody Market Size by Type (2021-2026) & (US$ Million)
Table 42. Latin America Anti-CD4 Antibody Market Size by Application (2021-2026) & (US$ Million)
Table 43. Middle East & Africa Anti-CD4 Antibody Revenue by Company (2021-2026) & (US$ Million)
Table 44. Middle East & Africa Anti-CD4 Antibody Market Share by Revenue, by Company (2021-2026)
Table 45. Middle East & Africa Anti-CD4 Antibody Market Size by Type (2021-2026) & (US$ Million)
Table 46. Middle East & Africa Anti-CD4 Antibody Market Size by Application (2021-2026) & (US$ Million)
Table 47. BosterBio Company Details
Table 48. BosterBio Business Overview
Table 49. BosterBio Anti-CD4 Antibody Product
Table 50. BosterBio Revenue in Anti-CD4 Antibody Business (2021-2026) & (US$ Million)
Table 51. BosterBio Recent Development
Table 52. ProSci Company Details
Table 53. ProSci Business Overview
Table 54. ProSci Anti-CD4 Antibody Product
Table 55. ProSci Revenue in Anti-CD4 Antibody Business (2021-2026) & (US$ Million)
Table 56. ProSci Recent Development
Table 57. Bio-Rad Company Details
Table 58. Bio-Rad Business Overview
Table 59. Bio-Rad Anti-CD4 Antibody Product
Table 60. Bio-Rad Revenue in Anti-CD4 Antibody Business (2021-2026) & (US$ Million)
Table 61. Bio-Rad Recent Development
Table 62. Bioss Company Details
Table 63. Bioss Business Overview
Table 64. Bioss Anti-CD4 Antibody Product
Table 65. Bioss Revenue in Anti-CD4 Antibody Business (2021-2026) & (US$ Million)
Table 66. Bioss Recent Development
Table 67. Thermo Fisher Scientific Company Details
Table 68. Thermo Fisher Scientific Business Overview
Table 69. Thermo Fisher Scientific Anti-CD4 Antibody Product
Table 70. Thermo Fisher Scientific Revenue in Anti-CD4 Antibody Business (2021-2026) & (US$ Million)
Table 71. Thermo Fisher Scientific Recent Development
Table 72. Biorbyt Company Details
Table 73. Biorbyt Business Overview
Table 74. Biorbyt Anti-CD4 Antibody Product
Table 75. Biorbyt Revenue in Anti-CD4 Antibody Business (2021-2026) & (US$ Million)
Table 76. Biorbyt Recent Development
Table 77. Abbexa Company Details
Table 78. Abbexa Business Overview
Table 79. Abbexa Anti-CD4 Antibody Product
Table 80. Abbexa Revenue in Anti-CD4 Antibody Business (2021-2026) & (US$ Million)
Table 81. Abbexa Recent Development
Table 82. Mabtech Company Details
Table 83. Mabtech Business Overview
Table 84. Mabtech Anti-CD4 Antibody Product
Table 85. Mabtech Revenue in Anti-CD4 Antibody Business (2021-2026) & (US$ Million)
Table 86. Mabtech Recent Development
Table 87. Bio X Cell Company Details
Table 88. Bio X Cell Business Overview
Table 89. Bio X Cell Anti-CD4 Antibody Product
Table 90. Bio X Cell Revenue in Anti-CD4 Antibody Business (2021-2026) & (US$ Million)
Table 91. Bio X Cell Recent Development
Table 92. R&D Systems Company Details
Table 93. R&D Systems Business Overview
Table 94. R&D Systems Anti-CD4 Antibody Product
Table 95. R&D Systems Revenue in Anti-CD4 Antibody Business (2021-2026) & (US$ Million)
Table 96. R&D Systems Recent Development
Table 97. MyBioSource Company Details
Table 98. MyBioSource Business Overview
Table 99. MyBioSource Anti-CD4 Antibody Product
Table 100. MyBioSource Revenue in Anti-CD4 Antibody Business (2021-2026) & (US$ Million)
Table 101. MyBioSource Recent Development
Table 102. GeneTex Company Details
Table 103. GeneTex Business Overview
Table 104. GeneTex Anti-CD4 Antibody Product
Table 105. GeneTex Revenue in Anti-CD4 Antibody Business (2021-2026) & (US$ Million)
Table 106. GeneTex Recent Development
Table 107. OriGene Technologies Company Details
Table 108. OriGene Technologies Business Overview
Table 109. OriGene Technologies Anti-CD4 Antibody Product
Table 110. OriGene Technologies Revenue in Anti-CD4 Antibody Business (2021-2026) & (US$ Million)
Table 111. OriGene Technologies Recent Development
Table 112. Novus Biologicals Company Details
Table 113. Novus Biologicals Business Overview
Table 114. Novus Biologicals Anti-CD4 Antibody Product
Table 115. Novus Biologicals Revenue in Anti-CD4 Antibody Business (2021-2026) & (US$ Million)
Table 116. Novus Biologicals Recent Development
Table 117. LSBio Company Details
Table 118. LSBio Business Overview
Table 119. LSBio Anti-CD4 Antibody Product
Table 120. LSBio Revenue in Anti-CD4 Antibody Business (2021-2026) & (US$ Million)
Table 121. LSBio Recent Development
Table 122. NSJ Bioreagents Company Details
Table 123. NSJ Bioreagents Business Overview
Table 124. NSJ Bioreagents Anti-CD4 Antibody Product
Table 125. NSJ Bioreagents Revenue in Anti-CD4 Antibody Business (2021-2026) & (US$ Million)
Table 126. NSJ Bioreagents Recent Development
Table 127. Abnova Corporation Company Details
Table 128. Abnova Corporation Business Overview
Table 129. Abnova Corporation Anti-CD4 Antibody Product
Table 130. Abnova Corporation Revenue in Anti-CD4 Antibody Business (2021-2026) & (US$ Million)
Table 131. Abnova Corporation Recent Development
Table 132. G Biosciences Company Details
Table 133. G Biosciences Business Overview
Table 134. G Biosciences Anti-CD4 Antibody Product
Table 135. G Biosciences Revenue in Anti-CD4 Antibody Business (2021-2026) & (US$ Million)
Table 136. G Biosciences Recent Development
Table 137. EpiGentek Company Details
Table 138. EpiGentek Business Overview
Table 139. EpiGentek Anti-CD4 Antibody Product
Table 140. EpiGentek Revenue in Anti-CD4 Antibody Business (2021-2026) & (US$ Million)
Table 141. EpiGentek Recent Development
Table 142. Elabscience Bionovation Company Details
Table 143. Elabscience Bionovation Business Overview
Table 144. Elabscience Bionovation Anti-CD4 Antibody Product
Table 145. Elabscience Bionovation Revenue in Anti-CD4 Antibody Business (2021-2026) & (US$ Million)
Table 146. Elabscience Bionovation Recent Development
Table 147. Santa Cruz Biotechnology Company Details
Table 148. Santa Cruz Biotechnology Business Overview
Table 149. Santa Cruz Biotechnology Anti-CD4 Antibody Product
Table 150. Santa Cruz Biotechnology Revenue in Anti-CD4 Antibody Business (2021-2026) & (US$ Million)
Table 151. Santa Cruz Biotechnology Recent Development
Table 152. RayBiotech Company Details
Table 153. RayBiotech Business Overview
Table 154. RayBiotech Anti-CD4 Antibody Product
Table 155. RayBiotech Revenue in Anti-CD4 Antibody Business (2021-2026) & (US$ Million)
Table 156. RayBiotech Recent Development
Table 157. HUABIO Company Details
Table 158. HUABIO Business Overview
Table 159. HUABIO Anti-CD4 Antibody Product
Table 160. HUABIO Revenue in Anti-CD4 Antibody Business (2021-2026) & (US$ Million)
Table 161. HUABIO Recent Development
Table 162. Cell Signaling Technology Company Details
Table 163. Cell Signaling Technology Business Overview
Table 164. Cell Signaling Technology Anti-CD4 Antibody Product
Table 165. Cell Signaling Technology Revenue in Anti-CD4 Antibody Business (2021-2026) & (US$ Million)
Table 166. Cell Signaling Technology Recent Development
Table 167. Miltenyi Biotec Company Details
Table 168. Miltenyi Biotec Business Overview
Table 169. Miltenyi Biotec Anti-CD4 Antibody Product
Table 170. Miltenyi Biotec Revenue in Anti-CD4 Antibody Business (2021-2026) & (US$ Million)
Table 171. Miltenyi Biotec Recent Development
Table 172. Kerafast Company Details
Table 173. Kerafast Business Overview
Table 174. Kerafast Anti-CD4 Antibody Product
Table 175. Kerafast Revenue in Anti-CD4 Antibody Business (2021-2026) & (US$ Million)
Table 176. Kerafast Recent Development
Table 177. SouthernBiotech Company Details
Table 178. SouthernBiotech Business Overview
Table 179. SouthernBiotech Anti-CD4 Antibody Product
Table 180. SouthernBiotech Revenue in Anti-CD4 Antibody Business (2021-2026) & (US$ Million)
Table 181. SouthernBiotech Recent Development
Table 182. Absolute Antibody Company Details
Table 183. Absolute Antibody Business Overview
Table 184. Absolute Antibody Anti-CD4 Antibody Product
Table 185. Absolute Antibody Revenue in Anti-CD4 Antibody Business (2021-2026) & (US$ Million)
Table 186. Absolute Antibody Recent Development
Table 187. St John's Laboratory Company Details
Table 188. St John's Laboratory Business Overview
Table 189. St John's Laboratory Anti-CD4 Antibody Product
Table 190. St John's Laboratory Revenue in Anti-CD4 Antibody Business (2021-2026) & (US$ Million)
Table 191. St John's Laboratory Recent Development
Table 192. Leading Biology Company Details
Table 193. Leading Biology Business Overview
Table 194. Leading Biology Anti-CD4 Antibody Product
Table 195. Leading Biology Revenue in Anti-CD4 Antibody Business (2021-2026) & (US$ Million)
Table 196. Leading Biology Recent Development
Table 197. Anti-CD4 Antibody Market Trends
Table 198. Anti-CD4 Antibody Market Drivers
Table 199. Anti-CD4 Antibody Market Challenges
Table 200. Anti-CD4 Antibody Market Restraints
Table 201. Research Programs/Design for This Report
Table 202. Key Data Information from Secondary Sources
Table 203. Key Data Information from Primary Sources


List of Figures
Figure 1. Anti-CD4 Antibody Product Picture
Figure 2. Global Anti-CD4 Antibody Market Share by Type: 2025 vs 2032
Figure 3. Monoclonal Antibody Features
Figure 4. Polyclonal Antibody Features
Figure 5. Global Anti-CD4 Antibody Market Share by Application: 2025 vs 2032
Figure 6. Biotechnology
Figure 7. Medical
Figure 8. University
Figure 9. Others
Figure 10. Anti-CD4 Antibody Report Years Considered
Figure 11. Global Anti-CD4 Antibody Market Size (US$ Million), Year-over-Year: 2021-2032
Figure 12. Global Anti-CD4 Antibody Market Size, (US$ Million), 2021 vs 2025 vs 2032
Figure 13. Global Anti-CD4 Antibody Market Share by Revenue, by Region: 2021 vs 2025
Figure 14. North America Anti-CD4 Antibody Revenue (US$ Million) Growth Rate (2021-2032)
Figure 15. Europe Anti-CD4 Antibody Revenue (US$ Million) Growth Rate (2021-2032)
Figure 16. Asia-Pacific Anti-CD4 Antibody Revenue (US$ Million) Growth Rate (2021-2032)
Figure 17. Latin America Anti-CD4 Antibody Revenue (US$ Million) Growth Rate (2021-2032)
Figure 18. Middle East & Africa Anti-CD4 Antibody Revenue (US$ Million) Growth Rate (2021-2032)
Figure 19. Global Anti-CD4 Antibody Market Share by Players in 2025
Figure 20. Global Top Anti-CD4 Antibody Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Anti-CD4 Antibody as of 2025)
Figure 21. The Top 10 and 5 Players Market Share by Anti-CD4 Antibody Revenue in 2025
Figure 22. North America Anti-CD4 Antibody Market Share by Type (2021-2026)
Figure 23. North America Anti-CD4 Antibody Market Share by Application (2021-2026)
Figure 24. Europe Anti-CD4 Antibody Market Share by Type (2021-2026)
Figure 25. Europe Anti-CD4 Antibody Market Share by Application (2021-2026)
Figure 26. Asia-Pacific Anti-CD4 Antibody Market Share by Type (2021-2026)
Figure 27. Asia-Pacific Anti-CD4 Antibody Market Share by Application (2021-2026)
Figure 28. Latin America Anti-CD4 Antibody Market Share by Type (2021-2026)
Figure 29. Latin America Anti-CD4 Antibody Market Share by Application (2021-2026)
Figure 30. Middle East & Africa Anti-CD4 Antibody Market Share by Type (2021-2026)
Figure 31. Middle East & Africa Anti-CD4 Antibody Market Share by Application (2021-2026)
Figure 32. BosterBio Revenue Growth Rate in Anti-CD4 Antibody Business (2021-2026)
Figure 33. ProSci Revenue Growth Rate in Anti-CD4 Antibody Business (2021-2026)
Figure 34. Bio-Rad Revenue Growth Rate in Anti-CD4 Antibody Business (2021-2026)
Figure 35. Bioss Revenue Growth Rate in Anti-CD4 Antibody Business (2021-2026)
Figure 36. Thermo Fisher Scientific Revenue Growth Rate in Anti-CD4 Antibody Business (2021-2026)
Figure 37. Biorbyt Revenue Growth Rate in Anti-CD4 Antibody Business (2021-2026)
Figure 38. Abbexa Revenue Growth Rate in Anti-CD4 Antibody Business (2021-2026)
Figure 39. Mabtech Revenue Growth Rate in Anti-CD4 Antibody Business (2021-2026)
Figure 40. Bio X Cell Revenue Growth Rate in Anti-CD4 Antibody Business (2021-2026)
Figure 41. R&D Systems Revenue Growth Rate in Anti-CD4 Antibody Business (2021-2026)
Figure 42. MyBioSource Revenue Growth Rate in Anti-CD4 Antibody Business (2021-2026)
Figure 43. GeneTex Revenue Growth Rate in Anti-CD4 Antibody Business (2021-2026)
Figure 44. OriGene Technologies Revenue Growth Rate in Anti-CD4 Antibody Business (2021-2026)
Figure 45. Novus Biologicals Revenue Growth Rate in Anti-CD4 Antibody Business (2021-2026)
Figure 46. LSBio Revenue Growth Rate in Anti-CD4 Antibody Business (2021-2026)
Figure 47. NSJ Bioreagents Revenue Growth Rate in Anti-CD4 Antibody Business (2021-2026)
Figure 48. Abnova Corporation Revenue Growth Rate in Anti-CD4 Antibody Business (2021-2026)
Figure 49. G Biosciences Revenue Growth Rate in Anti-CD4 Antibody Business (2021-2026)
Figure 50. EpiGentek Revenue Growth Rate in Anti-CD4 Antibody Business (2021-2026)
Figure 51. Elabscience Bionovation Revenue Growth Rate in Anti-CD4 Antibody Business (2021-2026)
Figure 52. Santa Cruz Biotechnology Revenue Growth Rate in Anti-CD4 Antibody Business (2021-2026)
Figure 53. RayBiotech Revenue Growth Rate in Anti-CD4 Antibody Business (2021-2026)
Figure 54. HUABIO Revenue Growth Rate in Anti-CD4 Antibody Business (2021-2026)
Figure 55. Cell Signaling Technology Revenue Growth Rate in Anti-CD4 Antibody Business (2021-2026)
Figure 56. Miltenyi Biotec Revenue Growth Rate in Anti-CD4 Antibody Business (2021-2026)
Figure 57. Kerafast Revenue Growth Rate in Anti-CD4 Antibody Business (2021-2026)
Figure 58. SouthernBiotech Revenue Growth Rate in Anti-CD4 Antibody Business (2021-2026)
Figure 59. Absolute Antibody Revenue Growth Rate in Anti-CD4 Antibody Business (2021-2026)
Figure 60. St John's Laboratory Revenue Growth Rate in Anti-CD4 Antibody Business (2021-2026)
Figure 61. Leading Biology Revenue Growth Rate in Anti-CD4 Antibody Business (2021-2026)
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed